Variants in CAPN3 Causing Autosomal Dominant Limb–Girdle Muscular Dystrophy Combined With Calpain‐3 Deficiency

<b></b> Limb-girdle muscular dystrophy Type 2A/R1 or calpain-3 deficiency is the most common autosomal recessive limb-girdle muscular dystrophy. However, in recent years, autosomal dominant cases and families with calpain-3 deficiency have been reported, and there is an emerging interest in looking for single variants in the calpain-3 gene in mildly to moderately affected patients with limb-girdle muscular dystrophy without biallelic gene variants in <i>CAPN3</i>. Here, we report four cases with creatine kinase levels above 1500 U/L, mild-to-moderate proximal weakness, waddling gait, and scapular winging. Two patients, a son and his father, are heterozygous for the <i>CAPN3</i> variant c.304C>T; p.(Pro102Ser), which has previously been reported in patients with compound heterozygous variants in <i>CAPN3</i>. The third and fourth patients were heterozygous for c.1371C>G; p.(Asn457Lys) and c.1490C>T; p.Ala497_Glu508del, respectively, neither of which has been reported before. All four patients had a near-complete loss of calpain-3 as determined by western blotting. While inherited autosomal dominant calpainopathy has now been firmly established, additional single cases of dominant calpainopathy are likely to emerge; some will be associated with clinical findings from parents or siblings, while others will arise from spontaneous mutations, but nevertheless with similar clinical findings of mild-to-moderate proximal weakness, increased level of creatine kinase, and near-complete loss of calpain-3 protein in affected individuals. This report expands the known number of variants causing dominant calpainopathy from 8 to 11 that appears to exclusively reside in two out of four domains that make up calpain-3. This information could aid in determining whether a <i>CAPN3</i> variant of unknown significance is pathological.

Authors

Institutions

Publication Details

Journal
Human Mutation
Published
2025-01-01
DOI
https://doi.org/10.1155/humu/9301465
Citations
3
Primary Topic
Calpain Protease Function and Regulation
Type
article
Field-Weighted Citation Impact
3.45
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Variants in CAPN3 Causing Autosomal Dominant Limb–Girdle Muscular Dystrophy Combined With Calpain‐3 Deficiency

Edoardo Malfatti, John Vissing, Thomas Krag, Mark A. Tarnopolsky et al.
3 citations
Human Mutation
Calpain Protease Function and Regulation
3.45
article

Variants in CAPN3 Causing Autosomal Dominant Limb–Girdle Muscular Dystrophy Combined With Calpain‐3 Deficiency

Edoardo Malfatti, John Vissing, Thomas Krag, Mark A. Tarnopolsky, Lauren Brady, Camille Verebi, Morten Dunø, France Leturcq, Emily Nasho
article en
3 citations

Abstract

<b></b> Limb-girdle muscular dystrophy Type 2A/R1 or calpain-3 deficiency is the most common autosomal recessive limb-girdle muscular dystrophy. However, in recent years, autosomal dominant cases and families with calpain-3 deficiency have been reported, and there is an emerging interest in looking for single variants in the calpain-3 gene in mildly to moderately affected patients with limb-girdle muscular dystrophy without biallelic gene variants in <i>CAPN3</i>. Here, we report four cases with creatine kinase levels above 1500 U/L, mild-to-moderate proximal weakness, waddling gait, and scapular winging. Two patients, a son and his father, are heterozygous for the <i>CAPN3</i> variant c.304C>T; p.(Pro102Ser), which has previously been reported in patients with compound heterozygous variants in <i>CAPN3</i>. The third and fourth patients were heterozygous for c.1371C>G; p.(Asn457Lys) and c.1490C>T; p.Ala497_Glu508del, respectively, neither of which has been reported before. All four patients had a near-complete loss of calpain-3 as determined by western blotting. While inherited autosomal dominant calpainopathy has now been firmly established, additional single cases of dominant calpainopathy are likely to emerge; some will be associated with clinical findings from parents or siblings, while others will arise from spontaneous mutations, but nevertheless with similar clinical findings of mild-to-moderate proximal weakness, increased level of creatine kinase, and near-complete loss of calpain-3 protein in affected individuals. This report expands the known number of variants causing dominant calpainopathy from 8 to 11 that appears to exclusively reside in two out of four domains that make up calpain-3. This information could aid in determining whether a <i>CAPN3</i> variant of unknown significance is pathological.

Human MutationVol. 2025(1)
Inserm (FR), Paris-Est Sup (FR), McMaster University Medical Centre (CA), Copenhagen University Hospital (DK), Rigshospitalet (DK), Assistance Publique – Hôpitaux de Paris (FR), Génétique Médicale & Génomique Fonctionelle (FR), Institut Mondor de Recherche Biomédicale (FR)
Good health and well-being
Openalex Percentile: Top 9%
Calpain Protease Function and Regulation
3.45
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.